STICHTING VUMC -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:200-300
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:100-200
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:700-800
Total Number of Projects:700-800
Networking Rank (Reputation):100-200
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):500-600

Ranking timeline:

Project Participation Performance(2016-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 75
As coordinator: 14
As participant: 55
Sole participant: 6
Coordinator / Participant Ratio: 0.25*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 7.832.226 55.809.575 7.484.613 2 12
2020 6.619.072 49.825.864 5.801.467 6 9
2019 22.176.012 102.675.617 13.460.793 4 14
2018 6.527.723 4.250.370 2.055.111 2 2
2017 5.407.488 50.188.027 2.853.901 2 4
2016 18.344.566 62.382.604 10.689.862 4 14

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE13
STICHTING VU12
JANSSEN PHARMACEUTICA NV11
KAROLINSKA INSTITUTE10
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM9
KATHOLIEKE UNIVERSITEIT LEUVEN9
NOVARTIS PHARMA8
UNIVERSITY COLLEGE LONDON8
ACADEMISCH ZIEKENHUIS GRONINGEN7
REGION HOVEDSTADEN7
UNIVERSITEIT GENT7
UNIVERSITY OF CAMBRIDGE7
KING'S COLLEGE LONDON6
PFIZER LIMITED6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
UNIVERSITE DE GENEVE6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
EUROPEAN CANCER PATIENT COALITION5
F HOFFMANNLA ROCHE5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
MEDIZINISCHE UNIVERSITAET WIEN5
STICHTING LYGATURE5
TAKEDA DEVELOPMENT CENTRE EUROPE5
TAKEDA PHARMACEUTICALS INTERNATIONAL5
UNIVERSITY OF HELSINKI5
UNIVERSITY OF NEWCASTLE UPON TYNE5
UNIVERSITY OF OSLO5
VRIJE UNIVERSITEIT BRUSSEL5
ACADEMIC MEDICAL CENTRE AMSTERDAM4
ALZHEIMER EUROPE4
BAYER4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS4
ELI LILLY AND COMPANY LIMITED4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
THE UNIVERSITY OF NOTTINGHAM4
UNIVERSITAETSKLINIKUM FREIBURG4
UNIVERSITY OF BOLOGNA4
UNIVERSITY OF COPENHAGEN4
UPPSALA UNIVERSITET4
VIB VZW4
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS4
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CELGENE MANAGEMENT SARL3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL3
EUROPEAN HEMATOLOGY ASSOCIATION3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA3
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA3
GMV SOLUCIONES GLOBALES INTERNET SAU3
GOETEBORGS UNIVERSITET3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
H LUNDBECK AS3
LEIDEN UNIVERSITY3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
MASARYKOVA UNIVERZITA3
NOVO NORDISK3
OSPEDALE PEDIATRICO BAMBINO GESU3
PROVINCIA LOMBARDO VENETA ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO FATEBENEFRATELLI3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG3
SANOFIAVENTIS3
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
UNIVERSIDAD DE NAVARRA3
UNIVERSITAET ULM3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITATSKLINIKUM BONN3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITEIT MAASTRICHT3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER3
ABBVIE INC2
ACADEMISCH ZIEKENHUIS LEIDEN2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
ANAXOMICS BIOTECH S L2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS2
ASTRAZENECA2
ASTRAZENECA AB2
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO2
BIOTRIAL2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL2
CENTRE DE REGULACIO GENOMICA2
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER2
CENTRO DE INVESTIGACION BIOMEDICA EN RED2
CHARLES UNIVERSITY PRAGUE2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CLINIQUES UNIVERSITAIRES SAINTLUC2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
CONCENTRIS RESEARCH MANAGEMENT2
CONSIGLIO NAZIONALE DELLE RICERCHE2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP2

Constancy:

Total number of partners: 1034
Partner loyalty:
Frequent Partner: (> 2 projects): 355
Rare Partner: 679
Frequent / Rare Partner Ratio: 0.52

Project overview:

Start dateProjectacronymrolefundingpartners
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-07-01PI3K/PTEN-related monogenic disease to understand cancer PIPgenparticipant4.099.07511
2021-06-01Individualized CARE for Older Persons with Complex Chronic Conditions at home and in nursing homes I-CARE4OLDcoordinator5.832.53614
2021-06-01Psychiatric Ratings using Intermediate Stratified Markers 2 PRISM 2participant3.980.90615
2021-04-01Tau Pathology in Alzheimer’s disease: Spreading and Resilience TAU-NOWparticipant1.500.0002
2021-04-01POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment POLYRISKparticipant5.991.07815
2021-04-01Non-coding RNA and Intercellular Communication in Cardiac Ageing NICCAcoordinator1.999.6901
2021-03-01A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis GLYTUNESparticipant3.744.22411
2021-03-01Training Network for Optimizing Adoptive T cell Therapy of Cancer T-OPparticipant4.100.95912
2021-03-01Anti-Cancer Light-Controllable Antibody-Peptide Conjugates ALISEparticipant745.2007
2021-02-01Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine TIGERparticipant6.900.0008
2021-01-01Evidence-based co-creation methodology for bridging the implementation gap between knowledge and action in health promotion. Health CASCADEparticipant4.058.1097
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-12-01Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic RESPONDparticipant6.172.02817
2020-11-01Drug discovery screening using human neurons HumanNeuronScreencoordinator150.0001
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-10-01Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration SkinTERMparticipant3.192.7368
2020-07-01Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS). Impentriparticipant3.662.9635
2020-06-01Chimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature AngioCARcoordinator175.5721
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00033
2020-05-01Molecular Imaging of Microglia MIMcoordinator175.5721
2020-04-01Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity EDUC8participant2.100.7099
2020-02-01Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells UNPACK PD-L1coordinator175.5721
2020-01-01Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity EarlyCauseparticipant5.997.38114
2020-01-01Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research MATCHcoordinator150.0001
2020-01-01A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities TO_AITIONparticipant5.990.51514
2020-01-01RISK-BASED SCREENING FOR CERVICAL CANCER RISCCcoordinator5.792.35511
2020-01-01EXposome Powered tools for healthy living in urbAN SEttings EXPANSEparticipant11.993.90720
2019-11-01Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis MIRIADEcoordinator4.015.37611
2019-10-01Exploitation of the SECRETory pathway for cancer therapy to address European research SECRETparticipant3.915.87212
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imagecoordinator15.000.00023
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis Host-TBcoordinator2.160.9262
2019-06-01Research and Training in Early Life Nutrition to Prevent Disease GROWTHparticipant2.133.1998
2019-05-01Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT) DISTINCTparticipant3.998.04810
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPcoordinator999.7106
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-03-01European network staff eXchange for integrAting precision health in the health Care sysTems ExACTparticipant1.090.20018
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2019-01-01Standard Operating Procedures for Research Integrity SOPs4RIparticipant3.999.86013
2019-01-01CeLac and European consortium for a personalized medicine approach to Gastric Cancer LEGACyparticipant3.577.43111
2019-01-01Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis IMPROVE-PDparticipant3.970.00623
2019-01-01Remote Assessment of Disease and Relapse – Alzheimer’s Disease RADAR-ADparticipant4.999.75717
2019-01-01CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease CardioReGenixparticipant14.839.77413
2019-01-01A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health EUCAN-Connectparticipant5.999.70413
2019-01-01automatic detection and localization of High frequency Oscillation in Paediatric Epilepsy HOPEparticipant1.214.40013
2018-09-01PET Imaging of Alpha-Synuclein Fibril Formation PET-AlphaSyparticipant4.100.37017
2018-06-01Virtue based ethics and Integrity of Research: Train-the-Trainer program for Upholding the principles and practices of the European Code of Conduct for Research Integrity VIRT2UEcoordinator2.800.00014
2018-01-01An EEG calibration toolkit for monitoring rehabilitation of stroke patients. MRI4DEEGparticipant150.0002

overview shows latest 50 from 75 projects (2016-01-01 - 2021-12-31)
A full list of projects can be found here: